PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 4 months ago Inside Information / Other news releases UZEDY® sales reach $117M in 2024, surpassing Teva's expectations. Medincell poised for $160M in 2025 with Olanzapine Long-Acting Injectable near launch. Key partnership and financial insights Sales Partnership Medincell Teva Pharmaceuticals UZEDY®
PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 4 months ago Informations privilégiées / Autres communiqués Les ventes de UZEDY® par Teva Pharmaceuticals atteignent 117 M$ en 2024, dépassant les prévisions, Medincell perçoit des royalties. Préparation de lancement de l'Olanzapine LAI (TEV-749 / mdc-TJK) Royalties Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY®
BRIEF published on 12/12/2024 at 21:35, 1 year 6 months ago Medincell Joins Euronext SBF 120 Index Market Capitalization Medincell CAC 40 Euronext SBF 120 Financial Visibility
BRIEF published on 12/12/2024 at 21:35, 1 year 6 months ago Medincell rejoint l'indice Euronext SBF 120 Capitalisation Boursière Visibilité Financière CAC 40 Euronext SBF 120 Médinecell
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 6 months ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Medincell intègre l'indice Euronext SBF 120 et CAC Mid 60, renforçant sa visibilité et attractivité pour les investisseurs. Découvrez les déclarations et impacts de cette intégration Euronext Intégration SBF 120 Medincell CAC Mid 60
PRESS RELEASE published on 12/10/2024 at 17:47, 1 year 6 months ago Medincell Rapport Financier semestriel 01-04-24 au 30-09-2024
BRIEF published on 11/28/2024 at 18:45, 1 year 6 months ago Medincell annonce une vidéoconférence pour ses résultats semestriels Résultats Semestriels Schizophrénie Medincell Videoconference Technologie BEPO
BRIEF published on 11/28/2024 at 18:45, 1 year 6 months ago Medincell Announces Video Conference for Half-Year Results Half-year Results Schizophrenia Medincell Videoconference BEPO Technology
PRESS RELEASE published on 11/28/2024 at 18:40, 1 year 6 months ago Informations privilégiées / Autres communiqués Medincell tiendra une vidéoconférence pour présenter ses résultats financiers semestriels le mardi 10 décembre 2024. La société développe des médicaments injectables à action prolongée dans divers domaines thérapeutiques Résultats Financiers Medincell Médicaments Injectables Videoconference Technologie BEPO
Published on 06/27/2026 at 16:50, 1 day 1 hour ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 16 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 17 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 18 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 19 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/28/2026 at 17:26, 27 minutes ago EQS-Adhoc: Correction of a release from 24/06/2026, 20:54 CET/CEST - Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/27/2026 at 00:05, 1 day 17 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 17 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 18 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 18 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
